Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Al Nasar Ahmed, Sehgal"'
Autor:
Armin Kraus, Bernhard Kratzer, Al Nasar Ahmed Sehgal, Doris Trapin, Matarr Khan, Nicole Boucheron, Winfried F. Pickl
Publikováno v:
Vaccines, Vol 12, Iss 7, p 797 (2024)
Virus-like nanoparticles (VNP) are regarded as efficient vaccination platforms and have proven to be useful for the non-anaphylactogenic delivery of allergen-specific immunotherapy in preclinical models previously. Herein, we sought to determine the
Externí odkaz:
https://doaj.org/article/d2ba35f4682a4fb4aaf38d4bc193e210
Autor:
Al Nasar Ahmed Sehgal, Jera Safran, Bernhard Kratzer, Pia Gattinger, Robert B. Stieger, Laszlo Musiejovsky, Doris Trapin, Paul Ettel, Ulrike Körmöczi, Arno Rottal, Kristina Borochova, Yulia Dorofeeva, Inna Tulaeva, Milena Weber, Katharina Grabmeier-Pfistershammer, Thomas Perkmann, Ursula Wiedermann, Rudolf Valenta, Winfried F. Pickl
Publikováno v:
Vaccines, Vol 12, Iss 4, p 377 (2024)
Background: COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has now become endemic and is currently one of the important respiratory virus infections regularly affecting mankind. The assessment of immunity against SA
Externí odkaz:
https://doaj.org/article/a38095d367404c3492f620969ca500df
Autor:
Erika Garner-Spitzer, Angelika Wagner, Venugopal Gudipati, Anna-Margarita Schoetta, Maria Orola-Taus, Michael Kundi, Renate Kunert, Patrick Mayrhofer, Johannes B. Huppa, Hannes Stockinger, Rita Carsetti, Pia Gattinger, Rudolf Valenta, Bernhard Kratzer, Al Nasar Ahmed Sehgal, Winfried F. Pickl, Walter Reinisch, Gottfried Novacek, Ursula Wiedermann
Publikováno v:
EBioMedicine, Vol 96, Iss , Pp 104788- (2023)
Summary: Background: Patients with inflammatory bowel disease (IBD) and healthy controls received primary SARS-CoV-2-mRNA vaccination and a booster after six months. Anti-TNF-α-treated patients showed significantly lower antibody (Ab) levels and fas
Externí odkaz:
https://doaj.org/article/af0e7bd0d2944b3bb222d123ec80fe21
Autor:
Pia Gattinger, Bernhard Kratzer, Al Nasar Ahmed Sehgal, Anna Ohradanova-Repic, Laura Gebetsberger, Gabor Tajti, Margarete Focke-Tejkl, Mirjam Schaar, Verena Fuhrmann, Lukas Petrowitsch, Walter Keller, Sandra Högler, Hannes Stockinger, Winfried F. Pickl, Rudolf Valenta
Publikováno v:
Vaccines, Vol 12, Iss 3, p 229 (2024)
Background: COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a recurrent endemic disease affecting the whole world. Since November 2021, Omicron and its subvariants have dominated in the spread of the d
Externí odkaz:
https://doaj.org/article/9bb6c13b42394d98b525c6240c46ea2e
Autor:
Jesús Borrego, Muhammad Umair Naseem, Al Nasar Ahmed Sehgal, Lipsa Rani Panda, Kashmala Shakeel, Attila Gaspar, Cynthia Nagy, Zoltan Varga, Gyorgy Panyi
Publikováno v:
Journal of Fungi, Vol 8, Iss 11, p 1215 (2022)
The Kv1.3 channel has become a therapeutic target for the treatment of various diseases. Several Kv1.3 channel blockers have been characterized from scorpion venom; however, extensive studies require amounts of toxin that cannot be readily obtained d
Externí odkaz:
https://doaj.org/article/e66c946cc5fc41abb7997fb4015c7f54
Autor:
Bernhard Kratzer, Doris Trapin, Pia Gattinger, Teresa Oberhofer, Al Nasar Ahmed Sehgal, Petra Waidhofer-Söllner, Arno Rottal, Ulrike Körmöczi, Katharina Grabmeier-Pfistershammer, Gerhard H. Kopetzky, Franz Tischer, Rudolf Valenta, Winfried F. Pickl
Publikováno v:
Vaccines, Vol 10, Iss 3, p 374 (2022)
Background: Prophylactic vaccination against infectious diseases may induce a state of long-term protection in the otherwise healthy host. However, the situation is less predictable in immunocompromised patients and may require adjustment of vaccinat
Externí odkaz:
https://doaj.org/article/0f5ba1e82d684f22ac8841ecda6bdb1a
Autor:
Panyi, Jesús Borrego, Muhammad Umair Naseem, Al Nasar Ahmed Sehgal, Lipsa Rani Panda, Kashmala Shakeel, Attila Gaspar, Cynthia Nagy, Zoltan Varga, Gyorgy
Publikováno v:
Journal of Fungi; Volume 8; Issue 11; Pages: 1215
The Kv1.3 channel has become a therapeutic target for the treatment of various diseases. Several Kv1.3 channel blockers have been characterized from scorpion venom; however, extensive studies require amounts of toxin that cannot be readily obtained d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::56854fbf1da0d5ed634df4a74c0e959a
Autor:
Jesús, Borrego, Muhammad Umair, Naseem, Al Nasar Ahmed, Sehgal, Lipsa Rani, Panda, Kashmala, Shakeel, Attila, Gaspar, Cynthia, Nagy, Zoltan, Varga, Gyorgy, Panyi
Publikováno v:
Journal of fungi (Basel, Switzerland). 8(11)
The Kv1.3 channel has become a therapeutic target for the treatment of various diseases. Several Kv1.3 channel blockers have been characterized from scorpion venom; however, extensive studies require amounts of toxin that cannot be readily obtained d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::085343c08351c414c81763aa73b35161
https://pubmed.ncbi.nlm.nih.gov/36422036
https://pubmed.ncbi.nlm.nih.gov/36422036
Autor:
Bernhard Kratzer, Larissa C. Schlax, Pia Gattinger, Petra Waidhofer‐Söllner, Doris Trapin, Peter A. Tauber, Al Nasar Ahmed Sehgal, Ulrike Körmöczi, Arno Rottal, Melanie Feichter, Teresa Oberhofer, Katharina Grabmeier‐Pfistershammer, Kristina Borochova, Yulia Dorofeeva, Inna Tulaeva, Milena Weber, Bernhard Mühl, Anna Kropfmüller, Bettina Negrin, Michael Kundi, Rudolf Valenta, Winfried F. Pickl
Publikováno v:
AllergyREFERENCES. 77(11)
Antibody-based tests are available for measuring SARS-CoV-2-specific immune responses but fast T-cell assays remain scarce. Robust T cell-based tests are needed to differentiate specific cellular immune responses after infection from those after vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b25b25eaf70ce17ab78676981f015e44
https://pubmed.ncbi.nlm.nih.gov/35690994
https://pubmed.ncbi.nlm.nih.gov/35690994